Publications
27
Citations
346
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Krystof Bankiewicz's research focuses on developing and testing targeted drug-delivery methods for brain tumors, especially recurrent high-grade glioma and glioblastoma. A central technique in his work is convection-enhanced delivery (CED), a method of infusing drugs directly into brain tissue under real-time MRI guidance, used to deliver experimental therapies like liposomal-irinotecan and the immunotoxin MDNA55. His work spans early-stage clinical trials (Phase I/IIb) as well as related methodological studies, such as MRI-guided viral vector delivery in non-human primates.
Publication output has been modest and somewhat irregular over the last decade, with 1-3 papers most years and a gap in 2022 and 2024, averaging about 1 publication per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma
Journal of Neuro-Oncology · 2025
- Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial
Neuro-Oncology · 2023
- Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma
Clinical Cancer Research · 2021
- MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin-4 receptor (IL4R) as compared to a matched synthetic control.
Journal of Clinical Oncology · 2020
- MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit.
European Journal of Cancer · 2020
- ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY
Neuro-Oncology · 2019
- ATIM-05. INTRATUMORAL DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, BY MRI-GUIDED CONVECTIVE DELIVERY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Neuro-Oncology · 2018
- Understanding biological activity, tumor response and pseudoprogression in a phase-IIb study of MDNA55 in adults with recurrent or progressive glioblastoma (GB)
Annals of Oncology · 2018
- Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus
Journal of Neuroscience Methods · 2017
- Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease
Journal of Alzheimer s Disease · 2016
- ACTR-33. A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
Neuro-Oncology · 2016
- Neuro-Oncology×5
- Journal of Neuro-Oncology×1
- Journal of Neuroscience Methods×1
- Journal of Alzheimer s Disease×1
- Clinical Cancer Research×1
- John R. Jacob
Medicine · The Ohio State University
- Fernando M. Núñez
Medicine · The Ohio State University
- Bradley Elder
Medicine · The Ohio State University
- Kamalakannan Palanichamy
Medicine · The Ohio State University
- Susan D. Bell
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile